Skip to main content
Log in

Teil 1: Risikofaktoren, Klinik, Diagnostik

Nichttuberkulösen Mykobakteriosen der Lunge auf der Spur

  • Fortbildung
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J 2020; 56: 2000535 [https://doi.org/10.1183/13993003.00535-2020].

  2. Winthrop KL, Marras TK, Adjemian J et al. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015. Ann Am Thorac Soc. 2020 Feb;17(2):178-185. doi: 10.1513/AnnalsATS.201804-236OC.

  3. Ringshausen F, Wagner D, de Roux A et al. Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014 Emerg Infect Dis. 2016 Jun; 22(6): 1102-05

  4. Adjemian J, Daniel-Wayman S, Ricotta E, Prevots DR. Epidemiology of nontuberculous mycobacteriosis. Semin Respir Crit Care Med 2018; 39: 325-35

  5. Priscilla P, Ly P, Dillard R et al. Medical Tourism and Postoperative Infections: A Systematic Literature Review of Causative Organisms and Empiric Treatment. Plastic and Reconstructive Surgery. 2018; 142(6):1644-51

  6. Becker SL, Schlotthauer U, Schäfers HJ et al. Epidemiology, Clinical Presentation, Diagnosis and Treatment of Infections Caused by Mycobacterium chimaera. Pneumologie. 2019 Aug;73(8):474-81 doi: 10.1055/a-0872-880

  7. J van Ingen, S A Bendien, W C M de Lange et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009 Jun;64(6):502-6. doi: 10.1136/thx.2008.110957.

  8. David E. Griffith, Timothy Aksamit, Barbara A. Brown-Elliott et al. on behalf of the ATS Mycobacterial Diseases Subcommittee. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med 2007. Vol 175. pp 367-416

  9. Mirsaeidi M, Hadid W, Ericsoussi B et al. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis. 2013;17:e1000-4.

  10. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 1992;101(6):1605-09. http://dx.doi.org/10.1378/chest. 101.6.1605

  11. Andrejak C, Nielsen R, Thomsen VO et al.Chronic respiratory disease, inhaled corticosteroids and risk of nontuberculous mycobacteriosis. Thorax. 2012;68:256-6

  12. Lake A, Ambrose L, Lipman M, Lowe D. "Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection BMC Medicine 2016; 14:54

  13. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416

  14. Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med 2011; 105:1718-25

  15. Richter R, Andres R, Diehl R et al. Tuberkulose, Mykobakteriose MiQ 05 (3. Auflage) 2019

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marion Heiß-Neumann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heiß-Neumann, M., Avsar, K. Nichttuberkulösen Mykobakteriosen der Lunge auf der Spur. Pneumo News 13, 41–47 (2021). https://doi.org/10.1007/s15033-021-2698-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-021-2698-8

Navigation